Bozkoç Vasi, N. Et Al. 2023. Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy. 25th European Congress of Endocrinology , (İstanbul, Turkey), 729-730.

Bozkoç Vasi, N., Yorulmaz, G., Garbioglu, D. B., Yıldız, B., & Dincer, M., (2023). Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy . 25th European Congress of Endocrinology (pp.729-730). İstanbul, Turkey

Bozkoç Vasi, Neslihan Et Al. "Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy," 25th European Congress of Endocrinology, İstanbul, Turkey, 2023

Bozkoç Vasi, Neslihan B. Et Al. "Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy." 25th European Congress of Endocrinology , İstanbul, Turkey, pp.729-730, 2023

Bozkoç Vasi, N. Et Al. (2023) . "Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy." 25th European Congress of Endocrinology , İstanbul, Turkey, pp.729-730.

@conferencepaper{conferencepaper, author={Neslihan Bozkoç Vasi Et Al. }, title={Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy}, congress name={25th European Congress of Endocrinology}, city={İstanbul}, country={Turkey}, year={2023}, pages={729-730} }